Page last updated: 2024-08-26

dimyristoylphosphatidylglycerol and Breast Cancer

dimyristoylphosphatidylglycerol has been researched along with Breast Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahiwale, R; Bothiraja, C; Mahadik, K; Pawar, A; Poudel, I1
Alipour, M; Heney, M; Mugabe, C; Omri, A; Suntres, Z; Th'ng, J; Vergidis, D1
Casale, F; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D1

Other Studies

3 other study(ies) available for dimyristoylphosphatidylglycerol and Breast Cancer

ArticleYear
Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2

    Topics: Animals; Antineoplastic Agents; Biotin; Breast Neoplasms; Chelating Agents; Chitosan; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Design; Humans; MCF-7 Cells; Molecular Targeted Therapy; Nanostructures; Phosphatidylglycerols; Rats; Tissue Distribution

2018
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.
    Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:12

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Female; Humans; Liposomes; Paclitaxel; Particle Size; Phosphatidylglycerols; Solubility

2010
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Colloids; Deoxycytidine; Dose-Response Relationship, Drug; Drug Compounding; Fatty Acids, Monounsaturated; Female; Gemcitabine; Humans; Kinetics; Lipids; Liposomes; Particle Size; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Quaternary Ammonium Compounds; Selective Estrogen Receptor Modulators; Solubility; Tamoxifen; Technology, Pharmaceutical

2012